UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000044597 |
|---|---|
| Receipt number | R000050941 |
| Scientific Title | The observational study of COVID-19 patients with cancer from Japanese registry database of COVID-19. |
| Date of disclosure of the study information | 2021/06/20 |
| Last modified on | 2024/08/09 15:50:54 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The observational study to evaluate the prognostic value of malignancies in patients with COVID-19 from Japanese registry database of COVID-19.
Acronym
The observational study of COVID-19 patients with cancer from Japanese registry database of COVID-19.
Scientific Title
The observational study of COVID-19 patients with cancer from Japanese registry database of COVID-19.
Scientific Title:Acronym
The observational study of COVID-19 patients with cancer from Japanese registry database of COVID-19.
Region
| Japan |
Condition
Condition
COVID-19 and cancer
Classification by specialty
| Pneumology | Hematology and clinical oncology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the influence on prognosis due to cancer in the COVID-19 patients in Japan.
Basic objectives2
Others
Basic objectives -Others
To investigate the poor prognostic factor in the patients with COVID-19 and cancer.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Mortality rate in the COVID-19 patients with cancer.
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
The patients who were enrolled in COVIREGI-JP.
Key exclusion criteria
1. The patients with missing data about survival information or cancer.
2. The patients who missed the essential data to be analyzed among other clinical data.
Target sample size
31364
Research contact person
Name of lead principal investigator
| 1st name | Osamu |
| Middle name | |
| Last name | Hataji |
Organization
Matsusaka Municipal Hospital
Division name
Respiratory Center
Zip code
5150073
Address
1550, Tonomachi
TEL
0598231515
mch1031@matsusaka.city-hosp.ne.jp
Public contact
Name of contact person
| 1st name | Kentaro |
| Middle name | Ito |
| Last name | Ito |
Organization
Matsusaka Municipal Hospital
Division name
Respiratory Center
Zip code
5150073
Address
1550, Tonomachi
TEL
0598231515
Homepage URL
kentarou_i_0214@yahoo.co.jp
Sponsor or person
Institute
Matsusaka Municipal Hospital
Institute
Department
Personal name
Funding Source
Organization
Matsusaka Municipal Hospital
Organization
Division
Category of Funding Organization
Local Government
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Matsusaka Municipal Hospital
Address
1550, Tonomachi
Tel
0598231515
kentarou_i_0214@yahoo.co.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 06 | Month | 20 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
31364
Results
Results date posted
Results Delayed
| Delay expected |
Results Delay Reason
Data analyses has been ongoing.
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2021 | Year | 01 | Month | 05 | Day |
Date of IRB
| 2020 | Year | 03 | Month | 02 | Day |
Anticipated trial start date
| 2021 | Year | 04 | Month | 26 | Day |
Last follow-up date
| 2021 | Year | 07 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
This study is a secondary use of data from the COVIREGI-JP study (UMIN000039873).
Management information
Registered date
| 2021 | Year | 06 | Month | 19 | Day |
Last modified on
| 2024 | Year | 08 | Month | 09 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050941
